Zdrowie i gospodarka · 21/08/2019

Psychopharmacologic Drugs Advisory Committee Meeting Canceled Due to New Information

The Psychopharmacologic Drugs Advisory Committee meeting originally scheduled for July 31, 2019, has been canceled, following a notice published in the Federal Register on June 14, 2019, due to new information regarding the application under review.